|ADAPs With Waiting Lists
(4,717 individuals in 12 states*, as of January 12, 2012)
||Number of Individuals on ADAP Waiting List
||Percent of the Total ADAP Waiting List
||Increase/Decrease From Previous Reporting Period
||Date Waiting List Began
|* As a result of FY2011 ADAP emergency funding, Alabama, Florida, Georgia, Idaho, Louisiana, Montana, North Carolina, Ohio, South Carolina, Utah, and Virginia were able to reduce the overall number of individuals on their waiting lists.
** Louisiana has a capped enrollment on their program. This number represents their current unmet need.
|ADAPs With Other Cost-Containment Strategies: Financial Eligibility
(445 Individuals in 6 States, as of November 9, 2011)
||Lowered Financial Eligibility
||500% to 200% FPL
||99 clients (September 2009)
||500% to 300% FPL
||Grandfathered in current clients from 301-500% FPL
||400% to 300% FPL
||Grandfathered in current clients from 301-400% FPL
||500% to 300% FPL
||257 clients (July 2010)
||550% to 300% FPL
||Grandfathered in current clients from 301-550% FPL
||400% to 250% FPL
||89 clients (September 2009)
ADAPs with Other Cost-containment Strategies (instituted since April 1, 2009, as of November 9, 2011)
Alabama: reduced formulary Arizona: reduced formulary Arkansas: reduced formulary Colorado: reduced formulary Florida: reduced formulary, transitioned 5,403 clients to Welvista from February 15 to March 31, 2011 Georgia: reduced formulary, implemented medical criteria, participating in the Alternative Method Demonstration Project Illinois: reduced formulary, instituted monthly expenditure cap ($2,000 per client per month), disenrolled clients not accessing ADAP for 90-days Kentucky: reduced formulary Louisiana: discontinued reimbursement of laboratory assays North Carolina: reduced formulary North Dakota: capped enrollment, instituted annual expenditure cap Ohio: reduced formulary Puerto Rico: reduced formulary Utah: reduced formulary Virginia: reduced formulary, restricted eligibility criteria, transitioned 204 clients onto waiting list Washington: instituted client cost sharing, reduced formulary, only paying insurance premiums for clients currently on antiretrovirals Wyoming: capped enrollment, reduced formulary, instituted client cost sharing
ADAPs Considering New/Additional Cost-containment Measures (before March 31, 2012***)
Alaska: reduce formulary Florida: lower financial eligibility Kentucky: reduce formulary Montana: reduce formulary Oregon: reduce formulary Puerto Rico: reduce formulary Tennessee: establish waiting list Wyoming: establish waiting list, lower financial eligibility, institute client cost sharing
Access to Medications (as of November 9, 2011)
Case management services are being provided to ADAP waiting list clients through ADAP (2 ADAP), Part B (9 ADAPs), contracted agencies (5 ADAPs), and other agencies, including other Parts of Ryan White (4 ADAPs).
For clients on ADAP waiting lists who are currently on or in need of medications, 11 ADAP waiting list states can confirm that ADAP waiting list clients are receiving medications through either pharmaceutical company patient assistance programs (PAPs), Welvista, or other mechanisms available within the state.
***March 31, 2012 is the end of ADAP FY2011. ADAP fiscal years begin April 1 and ends March 31. To receive The ADAP Watch, please e-mail Britten Pund at bpund@NASTAD.org.